MedPath

Does Tailored Education in Asthma Care Help Improve Patient Satisfaction, Adherence, and Quality of Life (TEACH) Trial

Phase 4
Completed
Conditions
Asthma
Registration Number
NCT00687310
Lead Sponsor
AstraZeneca
Brief Summary

The primary purpose of this study is to assess whether tailored patient education for patients on Symbicort® Turbuhaler® therapy improves patient satisfaction, adherence and Quality of Life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Patients with the diagnosis of asthma.
  • Patients with asthma, where the use of Symbicort® Turbuhaler® is indicated and would have been prescribed by the investigator as part of usual care.
  • Patient who have public or private insurance coverage for Symbicort® Turbuhaler® or are willing to pay for this medication for the duration of the trial.
Exclusion Criteria
  • Patients who have been treated wth Symbicort® Turbuhaler® in the preceding 3 months.
  • A history of smoking [i.e., 10 pack-years where one pack-year equals one pack (20 cigarettes) per day for one year, or equivalent].

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Patient's satisfaction with asthma educationAt the initial visit (Visit 1) and during the final call (Call 2) or at the time of premature discontinuation from the trial.
Secondary Outcome Measures
NameTimeMethod
Mini-asthma Quality of Life questionnaireVisit 1 and during calls 1 and 2
Asthma control parametersAt baseline, as well as during Call 1 and Call 2 for both the usual care group and the enducational intervention group.
PIKO meter usage assessmentDuring the Call 2 to the educational intervention group subjects who received the PIKO meter during their educational session.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.